Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$82.21
-1.65%today
MKT CAP
$7.0B
-7.9% · 1Y
Earnings History
-19.1%
-20.3%
-27.1%
+17.1%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$82.21
Low
$91.00
Analyst Mean
$118.86
High
$140.00
21 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-18.3x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+55.5%
Earnings Growth YoY-
Revenue Growth QoQ+1097.4%
5y Revenue CAGR-5.7%
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin-244.9%
Net Margin0.0%
ROE-27.1%
Debt / Equity5.23x
Free Cash Flow$-139,262,368
Insider Ownership2.1%
Institutional Ownership110.0%
Short % of Float15.11%
Days to Cover15.5d
1 Week-2.5%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MAINOLFI NELLO | Chief Executive Officer | Sale | 30,000 | $80.74 | $2.44M | 2026-04-29 |
| MAINOLFI NELLO | Chief Executive Officer | Conversion | 30,000 | $2.08 | $0.06M | 2026-04-29 |
| CHADWICK JEREMY G | Chief Operating Officer | Sale | 300 | $90.00 | $0.03M | 2026-04-22 |
| CHADWICK JEREMY G | Chief Operating Officer | Conversion | 300 | $30.17 | $0.01M | 2026-04-22 |
| CHADWICK JEREMY G | Chief Operating Officer | Sale | 6,551 | $90.00 | $0.59M | 2026-04-15 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| FMR, LLC | institution | 10.85% | $0.77B | +51.86% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 10.52% | $0.74B | +30.16% | 2025-12-31 |
| Avoro Capital Advisors LLC | institution | 9.09% | $0.64B | +17.71% | 2025-12-31 |
| Vanguard Group Inc | institution | 7.62% | $0.54B | +15.60% | 2025-12-31 |
| Price (T.Rowe) Associates Inc | institution | 7.49% | $0.53B | +20.83% | 2025-12-31 |
| BVF Inc. | institution | 6.69% | $0.47B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 6.08% | $0.43B | +14.63% | 2025-12-31 |
| Atlas Venture Life Science Advisors, LLC | institution | 5.66% | $0.40B | -4.83% | 2025-12-31 |
| Wellington Management Group, LLP | institution | 5.36% | $0.38B | -15.07% | 2025-12-31 |
| Siren, L.L.C. | institution | 4.00% | $0.28B | -4.12% | 2025-12-31 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | fund | 2.98% | $0.21B | +2.62% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.57% | $0.18B | +18.85% | 2025-12-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | fund | 2.53% | $0.18B | +0.73% | 2026-03-31 |
| T. Rowe Price New Horizons Fund, Inc. | fund | 2.39% | $0.17B | +6.29% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 1.85% | $0.13B | +12.37% | 2025-12-31 |
| SmallCap World Fund Inc | fund | 1.69% | $0.12B | +24.85% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.69% | $0.12B | +1.34% | 2026-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 1.50% | $0.11B | +4.49% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 1.32% | $0.09B | +10.70% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | fund | 1.05% | $0.07B | +13.61% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for KYMR.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.